d’Anglemont de Tassigny, X., Jiménez-Medina, A., López-López, I., & López-Barneo, J. (2025). Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism.
Citação norma Chicagod’Anglemont de Tassigny, Xavier, Alejandro Jiménez-Medina, Ivette López-López, e José López-Barneo. Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism. 2025.
Citação norma MLAd’Anglemont de Tassigny, Xavier, Alejandro Jiménez-Medina, Ivette López-López, e José López-Barneo. Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism. 2025.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.